An Open Label, Single-Center Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies.

Trial Profile

An Open Label, Single-Center Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Apr 2016

At a glance

  • Drugs Armodafinil (Primary)
  • Indications Lewy body disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Apr 2016 Results (n=20) presented at the 68th Annual Meeting of the American Academy of Neurology.
    • 21 Apr 2016 Results assessing neuropsychiatric morbidity presented at the 68th Annual Meeting of the American Academy of Neurology
    • 02 May 2012 Actual end date (March 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top